|Property||Resources - Mining|
|Resources - Oil & Gas||Technology|
|UK Commercial Property Trust||F&C Managed Portfolio Trust|
|Custodian REIT||Target Healthcare REIT|
|Blancco Technology Group||Collplant Holdings|
Aastrom Biosciences uses autologous cell therapy, ixmyelocel-T, to process and inject the patient’s own cells to treat orphan diseases. The current indication is dilated ischaemic cardiomyopathy (ixCELL-DCM), the Phase IIb recruited its first patients in April 2013. Eastern Capital holds over $44m of senior preference shares. Interest accrues until 2017 paid in non-voting B1 shares.
Abbey Protection is an integrated specialist insurance and consulting group focused on the delivery of legal and tax related professional fees insurance products and services to the UK SME sector.
Aberdeen Asset Management is an independent asset management group with global distribution and fund management investing across all the main asset classes.
Aberdeen New Thai Investment Trust's investment objective is to provide shareholders with long-term, above-average capital growth through investment in Thailand. Its assets are invested in a diversified portfolio of securities – substantially in the form of equities or equity-related securities such as convertible securities and warrants – in companies spread across a range of industries quoted on the Stock Exchange of Thailand (SET).
Aberdeen UK Tracker Trust (known as Edinburgh UK Tracker Trust until April 2013) invests in a portfolio designed to track closely the FTSE All-Share Index, in terms of both capital and income. It employs full replication of the FTSE 350 (96.85% of the All-Share at 31 July 2014) and also invests in the majority of FTSE Small-Cap Index stocks.
Ablon Group is a leading developer and investor in commercial and residential property in Central & Eastern Europe. It holds a portfolio of 33 assets, 14 income-producing investments and 19 development projects.
Abzena provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products.
Acarix, a Swedish company, has developed the CE-marked CADScor to enable about half of the patients to be ruled out from further, expensive testing. Pre-reimbursement sales will start in 2017. Full EU sales may start from 2019. US sales might start from 2021.
Accsys Technologies is an environmental science and technology company focused on the development, commercialisation and licensing of technologies for use in a wide range of everyday materials. Its main product is the treated softwood Accoya.
Achillion is engaged in the discovery and development of treatments for chronic HCV and progressing compounds from its research platform in its novel factor D programme. It is collaborating with J&J to develop and commercialise its HCV franchise, including a triple-regimen treatment, which is potentially best in class.
Acorda is a US-based biotech focused on treatments for neurological conditions. Its lead product Ampyra is approved in the US and the EU (where it is known as Fampyra and partnered to Biogen) to improve walking in patients with multiple sclerosis.
Acta develops and produces clean technology products for hydrogen generation, power generation and other industrial applications.
Action Hotels is an owner, developer and asset manager of branded three- and four-star hotels in the Middle East and Australia. The company listed on AIM in December, raising Â£30.5m before costs.
Active Biotech is a Swedish biotech firm focussed on autoimmune/inflammatory diseases and cancer. Its lead projects are laquinimod (partnered with Teva), tasquinimod (partnered with Ipsen) and the immunotherapy ABR-217620 (ANYARA).
Adherium is a digital health company developing technologies that address suboptimal medication use and remote patient management in chronic diseases. Clinical evidence shows that its Smartinhaler substantially increases adherence and reduces severe exacerbations in asthma.
Admiral was launched in 1993, becoming a public company in 2004. The group’s strategy has been to grow its share of the UK private motor insurance market, focussing on people who would otherwise have difficulty buying insurance. “confused.com” is the largest UK motor insurance aggregator website.
Advanced Computer Software Group is a leading provider of software and IT services to the UK health, care and business sectors. FY13 revenue was split Health & Care 22%, Business Solutions 49% and 365 Managed Services 29%.
Advanced Micro Devices (AMD) is a fabless semiconductor supplier of processors and system-on-chips (SoCs) for PCs, tablets, game consoles, cloud servers and embedded products.
Aegerion Pharmaceuticals is a US-based company focused on the commercialisation of lomitapide in the US (Juxtapid) and EU (Lojuxta). Lomitapide is the only oral treatment available to treat homozygous familial hypercholesterolemia (HoFH).
Aeterna Zentaris is a specialty biopharmaceutical company developing novel treatments in oncology and endocrinology. Its main pipeline drugs include zoptarelin doxorubicin, a peptide-drug conjugate between gonadotropin-releasing hormone (GnRH1) and doxorubicin, in Phase III development for resistant endometrial cancer, and MacrilenTM (macimorelin), which is in the process of NDA for the evaluation of adult growth hormone deficiency (AGHD).
Afferro is a West African iron ore explorer that owns 100% of the 2.5bt Nkout project and 100% of the Ntem project in Cameroon. Having delivered the PEA for Nkout, the company plans to advance the project to the PFS stage in 2013.
Afren is an independent oil and gas exploration and production company that was founded in 2004. It has a focus on West Africa, with current operations in Nigeria, Gabon, Ghana and Cote d’Ivoire.
African Barrick Gold was historically the Tanzanian gold mining business of Barrick and is one of Africa′s five largest gold producers with output from four mines, namely Bulyanhulu, Buzwagi, North Mara and Tulawaka.
African Minerals operates the Tonkolili iron ore project in Sierra Leone, with a JORC compliant resource of 12.8Bt. The project has a 60+ year mine life and is being developed on a staged basis. In 2013, the company sold 12.1Mt of iron ore and guides current year sales of 16-18Mwmt, aiming to reach the sustaining production run rate of 20Mtpa.
AFT Pharmaceuticals is a specialty pharmaceutical company that operates primarily in Australasia but has product distribution agreements across the globe. The company’s product portfolio includes prescription and over-the-counter drugs to treat a range of conditions and a proprietary nebuliser.
Agennix is a drug development company based in Germany and the US. Its is focused on oncology.
Akari Therapeutics is a biopharmaceutical company developing Coversin, a complement system inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and other immune disorders without a standard of care.
Albioma is an independent energy producer active in the thermal (biomass/coal), solar and anaerobic digestion power-generation sectors.
Alderon is a development company with a 75% stake in the Kami Iron Ore project in the Labrador Trough with an NI 43-101 compliant resource of 1.1Bt measured and indicated at 29.6%. 25% is owned by Hebei Iron & Steel, which has contracted to take 60% of production.
Alent is a global company that produces highly engineered and customised speciality chemicals and materials used primarily in the electronic, automotive and select high-growth market segments.
Algeta is a Norwegian biotech company with the leading position in alpha-emitting pharmaceuticals for oncology. Its lead product radium-223 has been approved in the US for the treatment of prostate cancer patients with bone metastases.
ALK Abello is a Danish biopharmaceutical company focused on allergy treatment. It sells a variety of immunotherapy products, including tablets, drops and injections. The allergy tablets are partnered with Merck in the US and with Torii in Japan.
Alkermes is an Ireland-based company that uses proprietary technologies to improve and enhance the delivery of drugs. Key growth drivers include partnered products Risperdal Consta, Invega Sustenna, Bydureon, Ampyra and a proprietary drug, Vivitrol.
All Star Minerals is a uranium exploration company focused on Sweden, where it owns 100% of the mineral exploration licences for three projects: Gilpas, Samon and Kuusivaara. The licences cover 111km sq in northern Sweden.
Alliance Pharma is a speciality pharmaceutical company that markets and distributes a number of established products, principally in the UK and Ireland. The company has grown rapidly through a number of acquisitions.
ATK is an aerospace, defence and commercial products company operating in 21 US states, Puerto Rico and internationally. The company is divided into three business groups: ATK Aerospace Group (28% of HY12 sales), ATK Defense Group (46%) and ATK Sporting Group (25%).
Allium Medical Solutions is a company focused on developing and marketing minimally invasive devices in various areas: cardiovascular, metabolic, genitourinary and gastrointestinal. The company has three selling product lines: Allium Stents, IBI (EndoFast) and Gardia Medical.
Allot Communications is a leading provider of network optimisation and service provisioning solutions to both wireless and wireline service providers as well as enterprises around the world. The company controls approximately 18% of the global DPI (deep packet inspection) market.
Alnylam Pharmaceuticals is a US biotech using RNA interference (RNAi) technology to develop therapeutics for infectious and metabolic diseases, and cancer. Internal resources are focused on therapeutics for rare/orphan, genetically defined disorders. A strategy that Alnylam has termed "5x15" is geared towards five such programmes being in late development by 2015.
APS presents a unique way for investors to gain exposure to a platform for the pooling of hedge funds.
Altamir aims to create value for shareholders over the long term by investing exclusively in or alongside European and global private equity funds managed or advised by Apax Partners, which specialise in TMT, Retail & Consumer, Healthcare, Business and Financial Services. Performance is benchmarked against the CAC Mid and Small and LPX Europe indices.
Altona holds a 49% interest in three exploration licences covering 2,500km square in the north of the Permian Arckaringa Basin, South Australia. Its immediate focus is completing a bankable feasibility study for a coal to liquids plus co-generation facility.
Amarantus BioScience is a US-based biotechnology company developing diagnostic and therapeutic products. Its lead product is LymPro, a blood-based diagnostic test for Alzheimer's disease. It has two other therapeutic products in development, eltoprazine in Phase II and MANF in preclinical studies.
Aminex is involved in the exploration, development and production of oil and gas reserves. Aminex has producing assets in the US, and exploration assets in the East African margin, Egypt and North Korea.
Amlin is an international insurer/reinsurer domiciled in London. It focuses on providing commercial insurance and reinsurance, operating in the UK, within Lloyd?s, Continental Europe and Bermuda.
Amur Minerals is an exploration and development company focused on base metal projects in Russia’s far east. The company’s principal asset is the Kun-Manie nickel sulphide deposit in the Amur Oblast, comprising almost 1Mt of contained nickel equivalent in at least five deposits.
Andes is an integrated energy company dedicated to oil and gas exploration, electricity generation and distribution in Argentina.
Angle is a specialist medtech company with a potentially disruptive platform technology. The proprietary Parsortix cell separation platform can harvest circulating tumour cells and other very rare cells from a blood sample for downstream analysis.
Anglo Pacific Group owns a number of royalties in mining projects with effective diversification of geographic and commodity risks. It continues to grow its portfolio with a target of developing near-term royalty cashflow.
Anthera Pharmaceuticals is a research stage biopharmaceutical company focused on developing products for cardiovascular and autoimmune disorders. Varespladib (ACS) and blisibimod (lupus) are approaching pivotal trial readouts.
API Group is a leading producer of specialised coated decorative and security materials used in the packaging of premium branded consumer goods. Globally recognised skills are in laminates, foils and holographics. Its operations are based in the UK, continental Europe, North America and Asia-Pacific.
Aratana is a biopharmaceutical company developing and commercialising prescription medicines for cats and dogs. Its lead drug candidates include AT-001 for pain, AT-002 for appetite stimulation, AT-003 for post-operative pain and several canine specific antibodies for cancer via acquisition of Vet Therapeutics.
Arbuthnot Banking Group is engaged in retail, investment and private banking and other financial services.
Arena is the UK's largest operator of horseracing fixtures with seven racecourses accounting for 26% of racing fixtures. A new hotel opened at Lingfield in May 2010 and Arena has on-going developments at Folkestone, Wolverhampton and Doncaster. It also owns 46% of At The Races.
Ariad is a US biotech company with a focus on cancer. Its R&D portfolio includes two projects in Phase III studies: ponatinib for chronic myelogenous leukaemia and ridaforolimus for soft tissue/bone sarcomas. The latter is licensed to Merck & Co.
Ariana is a gold exploration company focused on exploration and development projects in the Republic of Turkey.
Ark Therapeutics specialises in product development and GMP manufacturing contract services. It has gene therapy and small molecule pipeline candidates for vascular diseases and cancer, but requires partners for further development.
Following the sale of its trading activities, Armour group is a cash shell - objectives involve investment in high technology businesses.
Array BioPharma is a US pharmaceutical company focused on cancer and inflammatory diseases. Nine Phase II programmes are ongoing and seven are already partner funded, including two MEK inhibitors: selumetinib (AstraZeneca) and MEK162 (Novartis).
Arrowhead Research Corporation is a clinical-stage targeted therapeutics company with development programmes in oncology, obesity and hepatitis B. It has acquired various platform technologies for RNAi delivery (Roche) and peptide targeting (Alvos).
Formed in 2003 and listed in 2005, Asa Resource became the first African-owned, African-managed resource company to be listed on AIM. Its strategy is to pursue a multi-commodity, pan-African strategy, bringing appropriate management skills to bear on a diverse range of assets.
Ashley House supplies project management and consultancy services. These are primarily allied to the delivery of new medical facilities for NHS-led primary care, the management of assets and clinical services.
ASOS.com is a global online fashion and beauty retailer aimed at 'twenty-somethings' globally. ASOS has websites targeting the UK, USA, France, Germany, Spain, Italy and Australia, and ships to over 190 countries globally. It attracts 18.8m unique visitors and at end-August 2012 had 9.2m registered users and more than 5 million active customers.
With JORC-compliant open pit reserve of 247Mt, Ovoot is the second-largest Mongolian coking coal project after Tavan Tolgoi. The project is expected to be commissioned in 2017, having a very low capital cost and competitive opex. Ovoot's coking coal is MVHCC and is comparable to the highest-quality Australian benchmarks.
Astex Pharmaceuticals is a US-UK oncology focused drug-discovery company. Its lead programmes are AT13387 (Hsp90 inhibitor) and SGI-110 (hypomethylating agent). It also has collaborations with pharma companies.
Atalaya Mining owns 100% of the Riotinto copper project in Southern Spain. Production start-up at an initial rate of 5.0Mtpa was ahead of schedule and under budget. Commissioning of the Expansion Project, to double production to 9.5Mtpa is underway.
Athersys is a US biotech company developing MultiStem (allogeneic, bone marrow-derived stem cells). A Phase II trial with MultiStem in ischaemic stroke is complete, while further studies in AMI (Phase II) and ARDS (Phase IIa) are planned.
Atlantis Japan Growth Fund (AJGF) aims to achieve long-term capital growth through investing wholly or mainly in listed Japanese equities. Currently all investments are in Japanese equities and there is a bias to smaller and medium-sized companies.
Augean manages hazardous waste through five divisions: Radioactive Waste Services (3% of group revenues), Energy & Construction (37%), Industry & Infrastructure (21%), Augean Integrated Services – AIS (11%) and ANSS (27%).
BB Biotech (BION) is a Swiss-domiciled investment company, targeting long-term capital growth from biotechnology companies that are developing and marketing innovative drugs. At least 90% of the portfolio is in listed companies, primarily large and mid-cap names that are already profitable. It is benchmarked against the NASDAQ Biotech Index.
Aurizon Mines is a Canadian gold company with two major assets in the Abitibi region of Canada, namely Casa Berardi and the Heva & Hosco West Extension Areas plus options over a range of other properties.
Avalon Rare Metals is focused on the development of its three 100% owned Advanced Materials projects in Canada: Separation Rapids Lithium Project, East Kemptville Tin-Indium Project and Nechalacho Heavy Rare Earths Project.
AVEO Pharmaceuticals is a US biotech company focused on oncology. Tivozanib (triple VEGF inhibitor): Phase III trials for renal cell carcinoma, Phase I/II trials for colorectal, GI and breast cancers and partnered with Astellas ex-Asia. Ficlatuzumab (anti-HGF/c-MET antibody): Phase II trials for non-small cell lung cancer and solid tumours. AV-203 (ErbB3 antibody): preclinical studies for solid tumours and optioned/licensed to Biogen.
Avingtrans is a supplier of highly engineered components and services to the energy, medical, scientific and research communities, traffic management, automation and aerospace industries worldwide.
Aviva provides life and long-term savings products, asset management and all classes of general insurance. Based in the UK, the company employs over 54,000 people and serves more than 50 million customers in the UK, Europe, North America and Asia Pacific.
Avon Rubber designs, develops and manufactures products in the respiratory protection, defence (71% of 2016 sales) and dairy (29%) sectors. Its major contracts are with national security and safety organisations such as the DoD.
aap Implantate is a German medtech company, focused on developing, manufacturing and selling products for bone fractures. These include the recently launched LOQTEQ trauma plating system, in addition to bone cements.
AB Science is a French pharmaceutical company focused on the development of masitinib, an oral tyrosine kinase inhibitor. Eight Phase III trials are ongoing with masitinib across a range of indications, including multiple cancers, RA, asthma and MS. Masitinib was approved in Europe in 2008 as a treatment for tumours in dogs.
Abcam is a producer and distributor of research grade antibodies and related protein detection tools. It has a global distribution reach with key markets in the US, Europe and UK and the faster growing Far Eastern market including China. Its USP is the quantity and quality of it product characterisation data.
Aberdeen Private Equity Fund Ltd (APEF) is a private equity (PE) fund of funds, diversified by geography, investment type and stage, but with a high weighting to technology and venture capital that has helped it to achieve strong NAV and share price performance over the past year. A cash buffer of c 15% is held to meet commitments without having to liquidate portfolio holdings. The investment process focuses on detailed due diligence to ensure robustness of underlying manager selection. The discount to NAV has been stable at c 20-25% over the past year, but there is scope for it to narrow to a level more in line with peers.
Ablynx is a drug-discovery company with a proprietary technology platform. It is developing a novel class of therapeutic proteins called Nanobodies to treat a range of indications; five products are in clinical development.
Acal is a leading international supplier of customised electronics to industry. It designs, manufactures and distributes customer-specific electronic products and solutions to 25,000 industrial manufacturers.
accesso Technology Group (previously Lo-Q) provides technology solutions to the leisure and attractions industry. Its solutions include payment, ticketing, queue line management and digital content.
ACD's primary investment objective is to provide annual returns in excess of three-month LIBOR plus 5% over a rolling three-year period, and annual standard deviation of under 5%. The company's principal activity is to invest in an actively managed portfolio of predominantly debt-oriented hedge funds.
ACM is a fully integrated shipbroking business focused principally on the global oil tanker market. It arranges spot and time charters and offers a number of other services, including the sale and purchase of ships.
AIF's objective is to provide a high level of income with the opportunity for income growth and capital growth over the life of the company. AIF is geared through a ZDP stock. The portfolio is split into two pools, one (70-80% of assets) is invested in UK small-cap equities, the other is an income portfolio containing sterling fixed-interest instruments, reverse convertibles and high-yielding shares in other investment companies.
Actinium Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that develops drugs for the treatment of various cancers. Actimab-A is in Phase I/II clinical trials for acute myeloid leukaemia. Iomab-B is used for myeloconditioning for hematopoietic stem cell transplantation.
Activa Resources AG is a Germany-based company engaged in the discovery, acquisition, development and exploitation of oil and natural gas properties in the US. The company focuses on producing petroleum and natural gas products and is engaged in a variety of onshore oil and gas projects in Louisiana, Arkansas and Texas.
Active Energy Group (AEG) is evolving into an end-to-end environmental services and solutions business.
Addex Therapeutics is a Swiss biotech company with a leading position in the identification of allosteric modulators with activity in CNS, inflammatory and metabolic disease. Its pipeline includes two Phase II compounds, with one partnered with J&J.
Adler is a residential property company, targeting high-yielding portfolios in suburban locations across Germany. Its portfolio of c 32,000 residential units will increase to c 52,000 on completion of the acquisition of Westgrund Ag.
ADVA is a Germany-based manufacturer and supplier of next-generation telecommunications network equipment specialising in Metro and long-haul fibre optic WDM equipment and Ethernet access and aggregation devices.
Advanced Medical Solutions is a developer, producer and distributor of an extensive range of wound closure, sealants and wound care products. Its strategy is to develop existing technology platforms in conjunction with a pipeline of new wound closure products.
ADX Energy is an oil and gas exploration business listed in Australia with exploration activities in Tunisia, and offshore Italy and Romania. The group also has mining interests which are in the process of being demerged.
AEP Industries (AEPI) is a manufacturer of plastic packaging films. It manufactures and markets a diverse line of polyethylene and PVC products. Its products are mainly used in the packaging, transportation, beverage, food, automotive, pharmaceutical and chemical markets.
AFC Energy is an innovative producer of new generation fuel cell systems.
AFH Financial Group is a national independent financial advisory (IFA) and discretionary wealth management firm based in Bromsgrove. It has actively consolidated in the fragmented IFA market, making 14 acquisitions since floating in June 2011.
African Eagle is focused on developing its Dutwa nickel laterite project in Tanzania, where a total indicated and inferred resource of 107Mt has been defined (according to JORC) at a nickel grade of 0.92%.
African Petroleum is an Oslo-listed pure-play explorer with high working interests in 10 offshore licences across five West African countries. The company is in discussions to farm-down its blocks to fund drilling.
AGA Rangemaster is an international premium consumer brand owner focused primarily on kitchen appliances and interior furnishings.
Ai Claims Solutions provides credit hire and credit repair as well as other accident management solutions nationally. It represents non-fault drivers and insurers of at-fault drivers.
AIXTRON develops and manufactures deposition systems for the global semiconductor industry. These are used to build electronic and opto-electronic components based on compound, silicon and organic semiconductor materials.
Alabama Graphite is positioning itself as a major natural flake graphite producer in the US, and a principal supplier of battery-grade natural graphite to the green technology sector, in particular the manufacture of lithium-ion batteries (LiB). Its main project, Coosa, is strategically located in Alabama, US.
Alchemia is an ASX-listed drug development company with a late stage oncology pipeline and generic fondaparinux, which is sold in the US. The company has two platform technologies: HyACT (targeted cancer drug delivery using hyaluronic acid) and VAST (drug discovery).
Alexza develops products for the acute treatment of CNS disorders using its proprietary Staccato rapid inhalation drug delivery system. Adasuve is approved (US and EU) for the acute treatment of agitation in patients with schizophrenia or bipolar I disorder.
Alkane Resources is a multi-commodity explorer and developer, with projects in the central west region of New South Wales in Australia. Alkane owns the Tomingley Gold Operation and DZP rare metal and rare earths projects (both 100%).
All for One Steeb has established itself as the leading supplier of SAP solutions to the Mittelstand. Scale benefits, a broad solution offering and good alignment with SAP's partnership-driven SME strategy provide the key elements for robust performance to continue.
Allergy Therapeutics is a fully integrated speciality pharmaceutical company focused on preventing and treating allergy with allergy immunotherapy (allergy vaccines).
ATST’s objective is to be a core investment for investors seeking increasing value over the long term through investing primarily in a portfolio of global equities with a strong sustainability focus. The MSCI AC World index was introduced as a formal performance benchmark in October 2015 but sector and geographic allocations remain unconstrained. The focus is to generate a real return for shareholders over the medium to long term by a combination of capital growth and a rising dividend.
Allied Gold Mining is a gold explorer-producer. Its main assets are the Simberi Oxide Gold mine in Papua New Guinea and the Gold Ridge mine in the Solomon Islands.
Allocate Software is a leading provider of workforce and compliance optimisation solutions. The primary focus is on healthcare end markets although the company is also active in defence and maritime.
Almonty Industries is an independent tungsten producer, with operating mines in Spain, Australia and Portugal. It also has the large and low-cost development-stage flagship Sangdong (South Korea) and earlier stage Valtreixal (Spain) projects.
Alpha and Omega Semiconductor (AOS) is a supplier of discrete and integrated power semiconductors. It is based in California's Silicon Valley, registered in Bermuda, has a wafer fab in Oregon and assembly operations in Shanghai, but also uses foundry partners in Asia.
Altius Minerals conducts early-stage low-cost exploration primarily in Eastern Canada covering iron ore, gold, uranium, nickel and other base metals, retaining minority interests in partner-funded JVs once targets are identified. Altius also acquires royalty interests and makes selective equity investments.
The Kalsaka/Sega complex having reached the end of its productive life, Amara Mining is now developing the pre-feasibility stage Yaoure Gold Project in Cote d'Ivoire. It also has a development stage project in Baomahun in Sierra Leone.
Amarin is an Ireland-based (but mainly US operated) biotech focused on developing and commercialising therapeutics for cardiovascular disease. Its lead product Vascepa is an FDA-approved omega-3 fatty acid for lowering triglycerides.
Amerigo Resources produces copper and molybdenum under a long-term partnership with Codelco, the world's largest copper producer, through processing tailings at El Teniente, the world's largest underground copper mine, near Santiago, Chile.
Amino Technologies designs and supplies electronic systems, software and consultancy for IPTV (telco triple-play) applications, on-demand video and in-home multimedia distribution.
Amphion is a technology development and financing firm with a highly focused portfolio of principal investments in life-science and high-tech companies.
AmpliPhi develops bacteriophages, viruses that kill bacteria. A Phase I/II study of AmpliPhage-001 for PA infections in CF and a Phase I trial of AmpliPhage-002 in skin/wound infections are expected to start in H214.
ANADIGICS is a radio frequency semiconductor manufacturer of power amplifiers based on proprietary gallium arsenide (GaAs) technology for cellular handsets, tablets, notebooks, Wi-Fi base stations and cable television networks. It is based in New Jersey.
Formerly known as Angus & Ross, Angel Mining owns 100% of two mines in Greenland, namely the Nalunaq gold mine and the Black Angel lead/zinc mine. It has now restarted production at Nalunaq and plans to restart production at Black Angel in 2011.
Anglesey Mining has a 15.3% interest in Labrador Iron Mines (LIM), following LIM's public offering in February. LIM's commercial production began in Q212. Anglesey also owns 100% of the Parys Mountain zinc-copper-lead deposit in North Wales.
Animalcare Group is a leading supplier of veterinary medicines, identification and welfare products to the companion animal market.
Antofagasta is a major Chile-based copper mining group with interests in transport and water distribution. Its mining operations produce over 700ktpa copper and it has a number of major growth projects, predominantly in Chile, as well as several international exploration partnerships.
Aquarius Platinum is the world's fourth largest producer of platinum group metals and operates four mines in South Africa and one in Zimbabwe. These include Kroondal (50% interest), Marikana (50%), Blue Ridge (50%) Everest (100%) and Mimosa (50%). The company also owns two tailings retreatment operations.
Arbonia-Forster is an international technology group that provides innovative construction materials, machinery and services for the outer shell and interior design of buildings.
Ardea Biosciences (formerly Intrabiotics Pharmaceuticals) is a US biotech whose work is based on early assets it bought in 2007 from Valeant Pharmaceuticals. Its lead, lesinurad, has just entered Phase III; a Phase II MEK inhibitor anticancer is licensed to Bayer, while NNRTI work in HIV is on hold pending a partnership deal.
Arden Partners is a research-led institutional stockbroking firm. It provides its services to corporate and institutional clients, predominantly in the small and mid cap markets.
Arena is a US biotechnology company. Its lead project, lorcaserin (partnered with Eisai), is for the treatment of obesity. Arena also has a development pipeline of late preclinical and early clinical programmes, which it will develop in-house or with future development partners.
Arian Silver, listed on AIM and TSX, specialises in Mexican silver deposit exploration and development. Its San Jose mine is expected to enter production soon. Its other three projects are Calicanto and San Celso, located in Zacatecas, and Tepal in Michoacan.
ARM Holdings is a leading player in semiconductor intellectual property. Its customers include the world’s foremost chipmakers.
ArQule is a US biotech company engaged in development of small molecule drugs for cancer. Its lead product, tivantinib, is entering a pivotal Phase III trial for HCC and is in multiple Phase II studies in other indications, including mCRC and mCRPC. Tivantinib is partnered with Daiichi Sankyo and Kyowa Hakko Kirin.
Arria NLG develops software that processes industrial corporate transactional data from sensors and instruments into actionable, text-based information.
Arsenal Holdings plc operates a professional football club, Arsenal, with related commercial activities, and carries out property development, associated with its move to the Emirates Stadium.
artnet is an online business offering an integrated range of information and transaction services in the fine art, design, and decorative art markets. It has four divisions; Price Database, Galleries, Auctions and Advertising.
Ashmore Group is one of the world's leading emerging market investment managers. Based in London, Ashmore manages US$35.3bn (as at 30 June 2010) in pooled funds, segregated accounts and structured products.
Asian Growth Properties is an investor and developer of commercial and residential property in Hong Kong and mainland China, ie Chengdu, Nanjing and Guangzhou.
Aspermont is a multi-platform B2B media group. It is focused on the global resources industry, especially mining (80% of revenue and profit), but is becoming more diverse. It also runs a portfolio of investments in young resources groups.
Assura has two businesses: a £353m property portfolio yielding £21m in rents and a profitable £30m turnover growth pharmacy operation. The GP Provider Organisation (GPCo) businesses are now represented by a 24.9% stake in Virgin Healthcare Holdings plus a £4m loan note.
Athabasca Resources (ARL) is an E&P company that has agreed to buy a 50% interest in the Chard leases in Alberta, Canada. It aims to demonstrate commerciality of a new in-situ oil sands recovery technique, in a JV with Oil Recovery Services (ORS).
Atlantic Gold is an exploration and mining company focused on shale-hosted gold in Nova Scotia, Canada. The Touquoy gold project is its most advanced, with JORC proven and probable reserves of 454,000oz.
Based in Seattle, WA, Atossa Genetics is focused on the development of locally administered pharmaceuticals for the treatment of pre-cancer and early-stage breast cancer. Lead candidate afimoxigene topical gel is expected to start a Phase II study in 2016 in breast hyperplasia or DCIS.
TSX-listed Aurcana Corp owns 99.9% of the La Negra silver-copper-lead-zinc mine as well as 100% of the Shafter silver mine in Presidio County, Texas. The company aims to become a senior silver producer with production of 10Moz by 2014.
TSX- and AIM-listed Aureus Mining is a West African-focused gold developer/ explorer. Its flagship project is the 1.5Moz New Liberty gold project in Liberia.
AusTex was formed in 2006 and is an oil and gas explorer and producer with operations in the US mid-continent states of Kansas and Oklahoma. Its current focus is on developing its Mississippi Lime play.
Avanti Communications is a London-based fixed satellite services (FSS) provider. It sells satellite data communications services to service providers to key markets in Enterprise, Broadband, Carrier Services and Government. It has Ka-band capacity on four satellites, with two launches due in 2017.
Avesco is a leading international provider of services to the corporate presentation, entertainment and broadcast markets.
Avita Medical is developing and marketing a regenerative autologous skin product, ReCell, to treat a broad range of burns, wounds, scars and skin defects. ReCell is approved in Europe (CE mark), Canada, Australia and China. A Phase III study in the US is ongoing. Avita has operations in Australia, the UK and the US. Its shares are listed on the OTC (AVMXY) and ASX (AVH) markets.
Avnel Gold is a gold exploration and development company with operations in Mali, in West Africa. Avnel is focused on developing the Kalana Gold Project into a low cost, open-pit mining operation.
AWE is a Sydney-based, ASX-listed E&P company with producing assets in Australia, New Zealand and the US. In addition to conventional exploration assets in Australia, NZ and Indonesia, AWE is testing tight gas and shale gas in the Perth Basin and has taken an early-stage position in Indonesia.